Article 1 to 1 out of 1 concerning Raven biotechnologies, inc.
Raven Biotechnologies advances RAV18 through agreement with CMC ICOS Biologics(17 Mar 2008) Raven biotechnologies, Inc., a privately held company focused on the discovery and development of monoclonal antibody therapeutics (MAbs) for cancer and CMC ICOS Biologics, Inc. a contract manufacturing organization, announced they have entered into ...
Top
